Respiratory Viruses

Speed up Your Diagnosis of Respiratory Virus Infections

Overcome your respiratory viruses testing challenges

An accurate and timely medical diagnosis of infectious diseases is crucial for patients to receive optimal care, and to prevent further transmission. However, processing samples rapidly and mastering sudden increases in the sample throughput is not without challenges. The laborious and time-consuming nucleic acid extraction procedures, time, and cost of upscaling as well as supply chain issues are common bottlenecks.

BioEcho helps to overcome your respiratory viruses testing challenges by providing today’s fastest and simplest viral nucleic acid extraction. Our solutions enable diagnostic labs to scale up for high demands, to perform more tests in a shorter time, and to get answers faster.

Secret weapon BioEcho

Watch how a diagnostic laboratory managed to process 4000 Corona PCR tests per day:

Triple speed

Nucleic acids extraction three times faster with half the protocol steps of common methods.

Scale-up quickly

Massively increase throughput for peak sample demand.

Adapt throughput to your needs

Solution for small, middle- and high throughputs to scale up easily and provide flexibility in a cost-effective way.

Easy integration

Simple integration into your standard laboratory equipment.

Inhibitor-free nucleic acids

Highly pure respiratory virus RNA/DNA for reliable and reproducible RT-qPCR tests.

Reduced consumable costs

Less consumable consumption due to fewer workflow steps compared to other methods.

No supply bottlenecks

Our scalable production capacities ensure that your products are always available - even during periods of high demands! Another plus: less pipette tips needed means more independence in times of supply shortages.

Triple the speed & halve the steps

Reliably testing of samples in the shortest possible time while maintaining high sensitivity is essential for patient’s optimal care. Our EchoLUTION technology relies on a single-step nucleic acid isolation. Nucleic acids pass through the purification matrix without interaction, while impurities are held back and are completely removed. Different from the conventional silica-based bind–wash–elute nucleic acid extraction method, our technology allows today’s fastest and simplest nucleic acids extraction of respiratory viruses with highest purity.

With the EchoLUTION technology, no incubation is needed for viral lysis. After a centrifugation step to prepare the column or plate, the purification is accomplished in a single one-minute centrifugation. Compared to silica-based methods using the bind–wash–elute principle that include several centrifugation steps, prolonging the workflow drastically.

High compatibility

A variety of respiratory viruses (RNA, DNA, nonenveloped or enveloped) can be extracted with EchoLUTION (analyzed with qPCR or Luminex NxTAG® technology).

„During the pandemic, we sequenced many SARS-CoV-2 samples to gain more insights on the genetic basis of current SARS-CoV-2 variants. Using the EchoLUTION Viral RNA/DNA Swab Kit significantly reduced the time required to extract the SARS-CoV-2 RNA and resulted in high-quality RNA to ensure robust sequencing results.”

Moritz Hass,
Lab Manager, MVZ Sonnen-Gesundheitszentrum SOGZ, Germany

“Tourism is such an important industry for Cyprus and our laboratories must be as efficient as possible to deal with the huge numbers of passengers that visit our island every year. Thanks to the innovative extraction system of BioEcho, we have been able to eliminate bottlenecks at peak times and increase the overall efficiency of our COVID-19 PCR testing operations in a cost-effective manner without compromising the quality of our results”.

Dr. Christos Shammas,
Director of Bioanalysis, Limassol, Cyprus

“The automated RNA extraction workflow allowed us to process the large volumes of samples we received from hospitals and others much faster. The most important thing in fighting the Corona pandemic, especially at the beginning, was not to be able to send a positive result days later, but within 24 hours.”

Dr. Thomas Fenner,
Managing Director, Fenner laboratory, Germany